PG’s selective anti-colorectal actions occur via apoptosis by altering the expression of apoptosis-related genes [34, 35] and restoration of p53 tumor suppressor activity in chemo-resistant CRC stem cells [36]. This evidence concerns the gene TP53 and colorectal carcinoma.